QUEST LABORATORIES Stock Price Today (NSE: QUESTLAB)
Fundamental Score
QUEST LABORATORIES Share Price — Live NSE/BSE Price, Fundamentals & Analysis
QUEST LABORATORIES share price today is ₹104.40, down 0.60% on NSE/BSE as of 30 March 2026. QUEST LABORATORIES (QUESTLAB) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹142.40 (Cr). The 52-week high for QUESTLAB share price is ₹140.35 and the 52-week low is ₹75.15. At a P/E ratio of 10.41x, QUESTLAB is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 24.57% and a debt-to-equity ratio of 0.36.
QUEST LABORATORIES Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
QUEST LABORATORIES Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
QUEST LABORATORIES Share Price: A Conservative Value Investor's Perspective
The pharmaceutical industry, while possessing elements of inelastic demand due to essential healthcare needs, faces constant pressure from generic drug development and regulatory hurdles, making long-term capital allocation decisions crucial for sustained value. This analysis examines QUEST LABORATORIES share price, currently at ₹100.0, through the lens of a conservative value investor prioritizing capital safety. The company's current PE ratio stands at 10.41, suggesting a potentially undervalued position relative to broader market averages, but further investigation is warranted.
A key metric for assessing QUEST LABORATORIES' financial health is its Return on Capital Employed (ROCE) of 26.87%. This indicates a high level of efficiency in generating profits from invested capital. This robust ROCE can contribute to a strengthening economic moat. A high ROCE allows the company to reinvest profits at attractive rates of return, funding organic growth and potentially increasing shareholder value over time. This ability to generate superior returns on capital is a significant advantage in the competitive pharmaceutical landscape.
Comparing QUEST LABORATORIES to its peers provides further context. While direct comparison necessitates a deep dive into the specific business models and product portfolios, it's useful to broadly assess relative valuations and operational efficiencies. For instance, comparing QUEST LABORATORIES with
Mankind Pharma Ltd requires careful consideration of their respective management quality and capital allocation strategies. Evaluating factors like dividend policy, R&D spending, and strategic acquisitions helps to discern whether management is acting in the best interests of shareholders and protecting invested capital. Furthermore, comparing QUEST LABORATORIES share price with its peers, such as Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, provides insight into relative valuation.This analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, focusing on assessing the long-term sustainability and capital safety aspects of QUEST LABORATORIES. The observations presented here are based on publicly available data and should not be construed as investment recommendations. Further due diligence is essential before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
QUEST LABORATORIES Fundamental Analysis & Valuation Benchmarking
Educational evaluation of QUESTLAB across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Return on Equity (24.57%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (26.87%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 10.41 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Interest Coverage (10.95x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (66.78%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-22.48 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.32%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
QUEST LABORATORIES Financial Statements
Comprehensive financial data for QUEST LABORATORIES including income statement, balance sheet and cash flow
About QUESTLAB (QUEST LABORATORIES)
QUEST LABORATORIES (QUESTLAB) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a cur...rent market capitalisation of ₹142.40 (Cr). QUEST LABORATORIES has delivered a Return on Equity (ROE) of 24.57% and a ROCE of 26.87%. The debt-to-equity ratio stands at 0.36, reflecting the company's capital structure. Investors tracking QUESTLAB share price can monitor key metrics including P/E ratio, promoter holding of 66.78%, and quarterly earnings growth.
Company Details
QUESTLAB Share Price: Frequently Asked Questions
What is the current share price of QUEST LABORATORIES (QUESTLAB)?
As of 30 Mar 2026, 12:04 pm IST, QUEST LABORATORIES share price is ₹104.40. The QUESTLAB stock has a market capitalisation of ₹142.40 (Cr) on NSE/BSE.
Is QUESTLAB share price Overvalued or Undervalued?
QUESTLAB share price is currently trading at a P/E ratio of 10.41x, compared to the industry average of 31.77x. Based on this relative valuation, the QUEST LABORATORIES stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of QUESTLAB share price?
The 52-week high of QUESTLAB share price is ₹140.35 and the 52-week low is ₹75.15. These values are updated daily from NSE/BSE price data.
What factors affect the QUEST LABORATORIES share price?
Key factors influencing QUESTLAB share price include quarterly earnings growth (Sales Growth: 14.47%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is QUEST LABORATORIES a good stock for long-term investment?
QUEST LABORATORIES shows a 5-year Profit Growth of N/A% and an ROE of 24.57%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.36 before investing in QUESTLAB shares.
How does QUEST LABORATORIES compare with its industry peers?
QUEST LABORATORIES competes with major peers in the Pharmaceuticals. Investors should compare QUESTLAB share price P/E of 10.41x and ROE of 24.57% against the industry averages to determine competitive standing.
What is the P/E ratio of QUESTLAB and what does it mean?
QUESTLAB share price has a P/E ratio of 10.41x compared to the industry average of 31.77x. Investors pay ₹10 for every ₹1 of annual earnings.
How is QUESTLAB performing according to Bull Run's analysis?
QUESTLAB has a Bull Run fundamental score of 42.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does QUESTLAB belong to?
QUESTLAB operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting QUEST LABORATORIES share price.
What is Return on Equity (ROE) and why is it important for QUESTLAB?
QUESTLAB has an ROE of 24.57%, which indicates excellent management efficiency. ROE measures how efficiently QUEST LABORATORIES generates profits from shareholders capital.
How is QUESTLAB debt-to-equity ratio and what does it indicate?
QUESTLAB has a debt-to-equity ratio of 0.36, which indicates moderate leverage that should be monitored.
What is QUESTLAB dividend yield and is it a good dividend stock?
QUESTLAB offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in QUEST LABORATORIES shares.
How has QUESTLAB share price grown over the past 5 years?
QUESTLAB has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in QUESTLAB and why does it matter?
Promoters hold 66.78% of QUESTLAB shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in QUEST LABORATORIES.
What is QUESTLAB market capitalisation category?
QUESTLAB has a market capitalisation of ₹142 crores, placing it in the Small-cap category.
How volatile is QUESTLAB stock?
QUESTLAB has a beta of N/A. A beta > 1 suggests the QUEST LABORATORIES stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is QUESTLAB operating profit margin trend?
QUESTLAB has a 5-year average Operating Profit Margin (OPM) of 14.01%, indicating the company's operational efficiency.
How is QUESTLAB quarterly performance?
Recent quarterly performance shows QUEST LABORATORIES YoY Sales Growth of 14.47% and YoY Profit Growth of 8.56%.
What is the institutional holding pattern in QUESTLAB?
QUESTLAB has FII holding of 0.93% and DII holding of 1.39%. Significant institutional holding often suggests professional confidence in the QUEST LABORATORIES stock.